Recombinant multi-species MKNK2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MKNK2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the calcium/calmodulin-dependent protein kinases (CAMK) Ser/Thr protein kinase family, which belongs to the protein kinase superfamily. This protein contains conserved DLG (asp-leu-gly) and ENIL (glu-asn-ile-leu) motifs, and an N-terminal polybasic region which binds importin A and the translation factor scaffold protein eukaryotic initiation factor 4G (eIF4G). This protein is one of the downstream kinases activated by mitogen-activated protein (MAP) kinases. It phosphorylates the eukaryotic initiation factor 4E (eIF4E), thus playing important roles in the initiation of mRNA translation, oncogenic transformation and malignant cell proliferation. In addition to eIF4E, this protein also interacts with von Hippel-Lindau tumor suppressor (VHL), ring-box 1 (Rbx1) and Cullin2 (Cul2), which are all components of the CBC(VHL) ubiquitin ligase E3 complex. Multiple alternatively spliced transcript variants have been found, but the full-length nature and biological activity of only two variants are determined. These two variants encode distinct isoforms which differ in activity and regulation, and in subcellular localization. [provided by RefSeq, Aug 2011]
The Alternative Names of target: 2010016G11Rik,GPRK7,Gprk7,MAP kinase signal-integrating kinase 2 (MAPK signal-integrating kinase 2,MAP kinase-interacting serine/threonine-protein kinase 2,MKNK2,MNK2,Mknk2,Mnk2,Mnk2)
Go
to MKNK2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T99160-Ag-1/ GM-Tg-hg-T99160-Ag-2 | Human MKNK2 protein | Human |
| GM-Tg-rg-T99160-Ag-1/ GM-Tg-rg-T99160-Ag-2 | Rat MKNK2 protein | Rat |
| GM-Tg-mg-T99160-Ag-1/ GM-Tg-mg-T99160-Ag-2 | Mouse MKNK2 protein | Mouse |
| GM-Tg-cynog-T99160-Ag-1/ GM-Tg-cynog-T99160-Ag-2 | Cynomolgus/Rhesus macaque MKNK2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T99160-Ag-1/ GM-Tg-felg-T99160-Ag-2 | Feline MKNK2 protein | Feline |
| GM-Tg-cang-T99160-Ag-1/ GM-Tg-cang-T99160-Ag-2 | Canine MKNK2 protein | Canine |
| GM-Tg-bovg-T99160-Ag-1/ GM-Tg-bovg-T99160-Ag-2 | Bovine MKNK2 protein | Bovine |
| GM-Tg-equg-T99160-Ag-1/ GM-Tg-equg-T99160-Ag-2 | Equine MKNK2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T99160-Ag-1/ GM-Tg-hg-T99160-Ag-2;
GM-Tg-rg-T99160-Ag-1/ GM-Tg-rg-T99160-Ag-2;
GM-Tg-mg-T99160-Ag-1/ GM-Tg-mg-T99160-Ag-2; GM-Tg-cynog-T99160-Ag-1/ GM-Tg-cynog-T99160-Ag-2; GM-Tg-felg-T99160-Ag-1/ GM-Tg-felg-T99160-Ag-2; GM-Tg-cang-T99160-Ag-1/ GM-Tg-cang-T99160-Ag-2; GM-Tg-bovg-T99160-Ag-1/ GM-Tg-bovg-T99160-Ag-2; GM-Tg-equg-T99160-Ag-1/ GM-Tg-equg-T99160-Ag-2 |
| Products Name | MKNK2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | MKNK2 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MKNK2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.